Xing, Qi
Zhou, Xuelong
Zhou, Yin
Shi, Chonglong
Jin, Wenjie
Article History
Received: 9 January 2024
Accepted: 30 May 2024
First Online: 10 June 2024
Declarations
:
: This prospective randomized controlled trial was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University on March 15, 2022 (approval number: 2022-SR-035) and registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2200059715). All patients signed a written informed consent.
: Not applicable.
: The authors declare no competing interests.